US2025302871A1PendingUtilityA1
Colonic purgative composition
Est. expiryDec 23, 2039(~13.4 yrs left)· nominal 20-yr term from priority
Inventors:Il Kyu Yoon
A61K 33/06A61K 31/80A61K 9/2833A61K 9/2031A61K 9/2027A61K 9/1635A61P 1/10A61K 9/2846A61K 9/284A61K 47/20A61K 47/12A61K 47/32A61K 33/04A61K 31/4402
63
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates to a colonic purgative composition and a preparation method therefor, and more specifically, to a colonic purgative composition comprising sodium picosulfate, potassium sulfate and magnesium sulfate, and a preparation method therefor.
Claims
exact text as granted — not AI-modified1 .- 21 . (canceled)
22 . A method for bowel preparation before endoscopy comprising:
administering a colonic purgative composition comprising sodium picosulfate, potassium sulfate, magnesium sulfate and a water-soluble binder,
wherein the water-soluble binder is selected from the group consisting of polyvinylpyrrolidone, copolymers of vinylpyrrolidone and vinyl acetate, polyethylene glycol and combinations thereof; and
wherein a total dose of sodium picosulfate, potassium sulfate and magnesium sulfate before endoscopy is 22.26 to 24.62 g.
23 . The method according to claim 22 , wherein the colonic purgative composition further comprises simethicone.
24 . The method according to claim 23 , wherein the magnesium sulfate is magnesium sulfate tetrahydrate.
25 . The method according to claim 24 , wherein a daily dose of each component before colonoscopy is:
Sodium picosulfate: 7.5 to 10.5 mg, Potassium sulfate: 2.5 to 3.3 g, Magnesium sulfate tetrahydrate: 5.7 to 9 g, and Simethicone: 140 to 200 mg.
26 . The method according to claim 25 , wherein the daily dose of each component before colonoscopy is:
Sodium picosulfate: 7.5 to 10 mg, Potassium sulfate: 2.5 to 3.13 g, Magnesium sulfate tetrahydrate: 5.72 to 8.58 g, and Simethicone: 160 to 200 mg.
27 . The method according to claim 24 , wherein the colonic purgative composition further comprises a water-soluble lubricant.
28 . The method according to claim 27 , wherein the water-soluble lubricant is selected from the group consisting of sodium benzoate, sodium lauryl sulfate and combinations thereof.
29 . The method according to claim 27 , wherein the colonic purgative composition further comprises a water-soluble antioxidant.
30 . The method according to claim 9 , wherein the water-soluble antioxidant is selected from the group consisting of ascorbic acid, sodium ascorbate, fumaric acid, malic acid, potassium metabisulfite, sodium pyrosulfite, and combinations thereof.
31 . The method according to claim 22 , wherein the total dose of sodium picosulfate, potassium sulfate, magnesium sulfate and simethicone in combined dosage forms before endoscopy is 22.57 to 24.95 g.
32 . The method according to claim 22 , wherein the colonic purgative composition is administered in divided doses once on the day before the endoscopy and once on the day of the endoscopy.
33 . The method according to claim 22 , wherein the colonic purgative composition is administered in divided doses of 10 tablets the day before the endoscopy and 10 tablets on the day of the endoscopy.
34 . A method for preparing a colonic purgative composition, comprising:
mixing a first mixture comprising potassium sulfate, magnesium sulfate and simethicone; and a second mixture comprising sodium picosulfate, a water-soluble binder and a solvent,
wherein the water-soluble binder is selected from the group consisting of polyvinylpyrrolidone, copolymers of vinylpyrrolidone and vinyl acetate, polyethylene glycol and combinations thereof.
35 . The method for preparing a colonic purgative composition according to claim 34 , wherein the solvent is ethanol.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.